Mandate

Vinge advises FAM in connection with an investment in Nefab

April 17, 2015

Vinge advises when FAM AB, owned by the three largest Wallenberg Foundations, will become co-owner of Nefab by means of a targeted new share issue for SEK 1.1 billion. The Nordgren/Pihl family will continue as co-owners.

Nefab is currently active in 30 countries in Europe, North/South America and Asia. Products and services are supplied in these countries to customers in a number of different industry segments. Half or approximately 50% of Nefab’s sales come from global customers who need a supplier that can coordinate their packaging needs over several continents. Nefab’s global business set-ups are made possible through a strong local presence in the world’s leading industrial nations, and every year over 10,000 customers have their packaging needs met by the company. Nefab’s vision is to be the global partner for complete packaging solutions.

The deal is subject to approval by the relevant authorities.

Vinge’s team consists of responsible partner Jonas Johansson and associate Sofie Bjärtun, together with associates Kajsa Hallner and Nils-Fredrik Dehlin (corporate and M&A), counsel Johan Cederblad and associate Matilda Gustafsson (environment and real property), associates Marie Brommesson. Helena Håkansson (banking and finance), Malin Buch (commercial agreements), Åsa Gotthardsson, Lova Unge (both employment and benefits), Anna Möller, Karin Virding (both intellectual property), Nicklas Thorgerzon (IT), Linn Gustafsson (compliance) and project assistant Josefine Malm. Associates Grant McKelvey, Karl Samuelsson, Johan Wahlbom and Victoria Grossmann provide competition law advice.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025